Krystal Biotech, Inc. (KRYS)
267.14
-7.45
(-2.71%)
USD |
NASDAQ |
Feb 24, 16:00
266.90
-0.24
(-0.09%)
After-Hours: 20:00
Krystal Biotech Shareholders Equity (Annual) : 1.220B for Dec. 31, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Amicus Therapeutics, Inc. | 274.24M |
| DexCom, Inc. | 2.746B |
| Alkermes Plc | 1.465B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |